Arkea Bio has filed a notice of an exempt offering of securities to raise $32,999,992.00 in New Funding.

According to filings with the U.S. Securities and Exchange Commission, Arkea Bio is raising up to $32,999,992.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Arkea Bio
ArkeaBio is a global agricultural bioscience company developing a safe, cost-effective vaccine that reduces methane emissions from cattle worldwide. The company was the first to demonstrate a methane-reducing vaccine designed to combat greenhouse-gas emissions from cattle. Its solution is intended to be rapidly and sustainably scaled across the global cattle population while integrating seamlessly with existing farm practices. ArkeaBio states that the vaccine could reduce emissions at a cost of less than $100 per ton, without affecting the safety of meat or milk. The companys approach is designed to benefit farmers, governments, food producers, consumers, and the climate by supporting sustainable beef and dairy production. ArkeaBio is backed by industry-leading supporters, and Breakthrough Energy Ventures led a $12 million seed investment to help develop and commercialize its methane-reduction technology.

To learn more, visit https://www.arkeabio.com/
LinkedIn: https://www.linkedin.com/company/arkeabio/

Contact:
Frank Wooten, Chief Executive Officer
https://www.linkedin.com/in/frankwooten/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.